Innocrin Pharmaceuticals Inc Headquarters
Looking for information about Innocrin Pharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
Innocrin Pharma - Clinical-Stage Pharmaceutical Company
- https://innocrinpharma.org/
- Innocrin is a privately held, clinical-stage pharmaceutical company that discovers and develops novel, best-in-class oral selective inhibitors of CYP17 lyase, a validated target for the treatment of advanced breast and prostate cancer.
Innocrin Pharmaceuticals - Crunchbase Company Profile ...
- https://www.crunchbase.com/organization/innocrin-pharmaceuticals
- Headquarters Regions Research Triangle, East Coast, Southern US. Founded Date 2004. Founders Bill Moore. Operating Status Active. Last Funding Type Series D. Legal Name Innocrin Pharmaceuticals Holdings, LLC. Company Type For Profit. Phone Number (919) 467-8539. Innocrin discovers and develops novel oral inhibitors of CYP17 lyase, a validated ...Founded: 2004
Innocrin Pharmaceuticals, Inc. LinkedIn
- https://www.linkedin.com/company/innocrin-pharmaceuticals-inc-
- Innocrin Pharmaceuticals, Inc. 345 followers on LinkedIn. We are a privately held, clinical stage pharmaceutical company that develops novel, “best-in-class” oral CYP17 lyase inhibitors for ...
Innocrin Pharmaceuticals Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/1260770D:US
- Innocrin Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer.Leader: Dr Fredric N Eshelman "Fred", William R Moore
Innocrin Pharmaceuticals, Inc. Better Business Bureau ...
- https://www.bbb.org/us/nc/durham/profile/human-factors/innocrin-pharmaceuticals-inc-0593-90281515
- Innocrin Pharmaceuticals is a privately held, clinical stage pharmaceutical company that develops oral CYP17 lyase inhibitors for the treatment of castration-resistant prostate cancer (CRPC) and ...
Innocrin Pharmaceuticals Company Profile: Valuation ...
- https://pitchbook.com/profiles/company/100550-71
- Apr 20, 2015 · Innocrin Pharmaceuticals General Information Description. Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes …
Our Pipeline Innocrin Pharma
- https://innocrinpharma.org/our-pipeline
- Our Pipeline. Dual Mechanism Selective CYP17 Lyase and AR Inhibitors. Seviteronel (INO-464), a selective CYP17 lyase and AR inhibitor and the broad collection of multiple patented chemical classes of related compounds that were invented by scientists at Viamet Pharmaceuticals are wholly owned by Innocrin. Innocrin has identified high priority ...
Innocrin’s Competitors, Revenue, Number of Employees ...
- https://www.owler.com/company/innocrin
- Innocrin is a pharmaceutical company that discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer. Innocrin was founded in 2014. Innocrin's headquarters is located in Durham, North Carolina, USA 27703. It has r...
Innocrin Pharmaceuticals, Inc. Granted SME Status ...
- https://www.businesswire.com/news/home/20170620005143/en/Innocrin-Pharmaceuticals-Granted-SME-Status-Designation-European
- Jun 20, 2017 · Innocrin Pharmaceuticals, Inc. Charles Osborne, CFO, +1-919-200-6325 Release Summary Innocrin Pharmaceuticals, Inc. granted SME …
Our Locations Ecolab
- https://www.ecolab.com/about/locations
- Ecolab Inc. 1 Ecolab Place St. Paul, MN 55102. Ecolab Customer Service Phone: +1-800-352-5326 Nalco Water Customer Service Phone: +1-800-288-0879
Have you found Innocrin Pharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.